Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Genentech-s-Tecentriq-Plus-Chemotherapy-Carboplatin-and-Abraxane-as-an-Initial-Treatment-Helpe-27460725/?utm_source=whatsapp&utm_medium=social&utm_campaign=share